April 9 - 11, 2014    Washington DC , USA
The 4th annual World Orphan Drug Congress USA is where industry, government and payers come to develop new strategies and partnerships to advance orphan drug development and patient access.

This is the largest, global event that stakeholders go to annually.

The event is dedicated to fostering partnerships and collaboration. It is about expediting orphan drug development and articulating its value, from discovery to patient access, so that manufacturers are guaranteed full and speedy reimbursement.

Who will attend
Confirmed participants include:
Emil Kakkis, CEO and President, Ultragenyx Pharmaceutical
Leonard Lance, Congressman, US House of Representatives
Pat Furlong, Founder and President, Parent Project Muscular Dystrophy
Anne Pariser, Associate Director for Rare Diseases, CDER, FDA
Pranesh Chakraborty, Director, Newborn Screening Ontario
Joanna Horobin, CMO, Verastem
Jimmy Lin, Founder and President , Rare Genomics Institute

Venue

Location: Grand Hyatt Washington
Escape to extraordinary elegance at Grand Hyatt Washington. Centrally located in trendy Penn Quarter – with convenient in-lobby Metro Center access – this downtown Washington DC hotel is an ideal spot..
Contact 1000 H Street NW , D.C., USA 20001 Washington , USA
+1 202 582 1234

Related events

World Orphan Drug Congress USA April 20 - 22, 2016
World Orphan Drug Congress USA April 9 - 11, 2015
World Orphan Drug Congress USA April 9 - 11, 2014
World Orphan Drug Congress USA April 9 - 11, 2013
World Orphan Drug Congress USA April 10 - 13, 2012
World Orphan Drug Congress USA April 13 - 15, 2011
World Orphan Drug Congress USA November 29 - December 1, 2010